Skip to content

Organon & Co.

OGN· NYSECore metricsCIK 1821825

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · +0.07%
Market cap
$3.65B
262.62M shares
Filings
466
$1.57B
Q3 2026−2.9% FY25 yoy
$164.00M
Q3 2026−78.4% FY25 yoy
—
—
—
$579.00M
Q3 2026derived−29.6% FY25 yoy
$0.60
Q3 2026−78.4% FY25 yoy
$1.46B
Q3 2026−15.0% FY25 yoy
$3.65B
17.1×
0.6×
3.1×
18.49%
0.55%

Twelve months to Sep 30, 2026 · derived

Price

$13.90+84.84%+$6.38past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$6.22BFY 2025
$7.78B0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$6,216,000,000reported
FY 20242024-12-31$6,403,000,000reported
FY 20232023-12-31$6,263,000,000reported
FY 20222022-12-31$6,174,000,000reported
FY 20212021-12-31$6,304,000,000reported
FY 20202020-12-31$6,532,000,000reported
FY 20192019-12-31$7,777,000,000reported

Capital returns

Dividends and buybacks · FY2019 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$88.00M—$88.00M$0.34260.32M sh+0.9%16.4%
FY2024$297.00M—$297.00M$1.12257.95M sh+0.9%38.9%
FY2023$294.00M—$294.00M$1.12255.64M sh+0.5%53.6%
FY2022$290.00M—$290.00M$1.12254.38M sh+0.3%43.8%
FY2021$145.00M—$145.00M$0.56253.64M sh—7.4%

Segments

Revenue by Geography, FY2019 to FY2025FY2019Europe and Canada · FY2019 · $1.89BU.S. · FY2019 · $2.02BLatin America, Middle East, Russia, and Africa · FY2019 · $923.00MAsia Pacific and Japan · FY2019 · $1.79BChina · FY2019 · $1.03BOther · FY2019 · $124.00MFY2020Europe and Canada · FY2020 · $1.73BU.S. · FY2020 · $1.41BLatin America, Middle East, Russia, and Africa · FY2020 · $857.00MAsia Pacific and Japan · FY2020 · $1.54BChina · FY2020 · $873.00MOther · FY2020 · $133.00MFY2021Europe and Canada · FY2021 · $1.74BU.S. · FY2021 · $1.38BLatin America, Middle East, Russia, and Africa · FY2021 · $841.00MAsia Pacific and Japan · FY2021 · $1.17BChina · FY2021 · $933.00MOther · FY2021 · $233.00MFY2022Europe and Canada · FY2022 · $1.63BU.S. · FY2022 · $1.44BLatin America, Middle East, Russia, and Africa · FY2022 · $895.00MAsia Pacific and Japan · FY2022 · $1.14BChina · FY2022 · $917.00MOther · FY2022 · $151.00MFY2023Europe and Canada · FY2023 · $1.67BU.S. · FY2023 · $1.48BLatin America, Middle East, Russia, and Africa · FY2023 · $965.00MAsia Pacific and Japan · FY2023 · $1.13BChina · FY2023 · $864.00MOther · FY2023 · $154.00MFY2024Europe and Canada · FY2024 · $1.76BU.S. · FY2024 · $1.57BLatin America, Middle East, Russia, and Africa · FY2024 · $1.03BAsia Pacific and Japan · FY2024 · $1.05BChina · FY2024 · $847.00MOther · FY2024 · $137.00MFY2025Europe and Canada · FY2025 · $1.62BU.S. · FY2025 · $1.60BLatin America, Middle East, Russia, and Africa · FY2025 · $1.07BAsia Pacific and Japan · FY2025 · $1.00BChina · FY2025 · $829.00MOther · FY2025 · $93.00M
LineFY2025ShareChange
Europe and Canada$1.62B26%−8.2%
U.S.$1.60B26%+2.0%
Latin America, Middle East, Russia, and Africa$1.07B17%+3.7%
Asia Pacific and Japan$1.00B16%−4.8%
China$829.00M13%−2.1%
Other$93.00M1.5%−32.1%
Total$6.22B

From the 10-K filed Feb 24, 2026OGN

Pharmaceutical preparations

Organon & Co. is the 16th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR